Sårbehandling > Studier > Observationsstudie bekræfter: Atrauman Ag fremmer sårheling

Observationsstudie bekræfter: Atrauman Ag fremmer sårheling

15.03.2006 Med sølvforbindingen Atrauman Ag kan patienter med kroniske eller langsomt helende sår behandles effektivt. Dette er blevet bekræftet i et observationsstudie med 624 patienter.

Chronic or slow- healing wounds are often contaminated with bacteria. In addition to antibiotic therapy, dressings are frequently used on these wounds. The anti-bacterial effect of the silver-containing ointment dressing Atrauman Ag has been confirmed in clinical studies and laboratory tests. When Atrauman Ag is applied to the wound, the dressing forms silver ions on its metallic surface on contact with exudate. The silver ion formation is locally restricted to the wound dressing. When bacteria come into contact with the dressing silver ions bind to and destroy these micro-organisms. The wound exudate together with the killed bacteria and the endotoxins formed in the process are absorbed into the secondary wound dressing. An observational study in 624 patients has proven that Atrauman Ag significantly promotes healing of chronic and slow-healing wounds. The study involved 211 practicing physicians including general practitioners, dermatologists, surgeons and internists - as well as 11 nursing services. The patients were treated with Atrauman Ag for 23 days on average. A large number of wounds were venous leg ulcers. During the observational study, the proportion of wounds covered extensively or completely with slough was reduced by 35% to 3%. Granulation and epithelial tissue markedly increased, the wound size was significantly reduced and there were substantially fewer infected wounds. Physicians and patients reported that wound conditions had improved or even had significantly improved through the use of Atrauman Ag and confirmed the excellent tolerability. The quality of life for patients was also improved with decreased wound pain.